2. HOWLADER N, NOONE AM, KRAPCHO M, GARSHELL J, MILLER D, ALTEKRUSE SF, et al. (eds) SEER Cancer Statistics Review, 1975-2011, National Cancer Institute Bethesda, MD, http://seercancergov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
4. RAJKUMAR SV, DIMOPOULOS MA, PALUMBO A, BLADE J, MERLINI G, MATEOS MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014; 15(12):e538-48.10.1016/S1470-2045(14)70442-5
6. SOUTAR R, LUCRAFT H, JACKSON G, REECE A, BIRD J, LOW E, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004; 124(6):717-26.10.1111/j.1365-2141.2004.04834.x15009059
7. KILCIKSIZ S, KARAKOYUN-CELIK O, AGAOGLU FY, HAYDAROGLU A. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. Scientific World Journal. 2012; 2012:895765.10.1100/2012/895765335466822654647
8. INTERNATIONAL MYELOMA WORKING GROUP. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003; 121(5):749-57.10.1046/j.1365-2141.2003.04355.x
9. GILLMORE JD, WECHALEKAR A, BIRD J, CAVENAGH J, HAWKINS S, KAZMI M, et al. Guidelines on the diagnosis and investigation of AL amyloidosis. Br J Haematol. 2015; 168(2):207-18.10.1111/bjh.1315625312307